San Diego, CA, United States of America

Duong Hoang Nguyen

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Calidi Biotherapeutics, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Duong Hoang Nguyen. Retrieved from https://idiyas.com/inventor/duong-hoang-nguyen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Duong Hoang Nguyen: Innovator in Oncolytic Viral Therapy

Introduction

Duong Hoang Nguyen is a prominent inventor based in San Diego, California. He has made significant contributions to the field of cancer treatment through his innovative work in oncolytic viral therapy. His research focuses on enhancing the effectiveness of this therapy, which utilizes modified viruses to target and destroy cancer cells.

Latest Patents

Duong Hoang Nguyen holds a patent for "Enhanced systems for cell-mediated oncolytic viral therapy." This patent outlines advanced systems designed to potentiate cell-mediated oncolytic viral therapy. It also includes modified viruses for these systems and methods for treating cancers by administering such systems.

Career Highlights

Nguyen is currently associated with Calidi Biotherapeutics, Inc., a company dedicated to developing innovative cancer therapies. His work at Calidi Biotherapeutics has positioned him as a key player in the advancement of oncolytic viral therapy.

Collaborations

He collaborates with notable colleagues, including Antonio Fernandez Santidrian and Dobrin Draganov, who contribute to the research and development efforts in the field of cancer treatment.

Conclusion

Duong Hoang Nguyen's innovative work in oncolytic viral therapy exemplifies the potential of modified viruses in cancer treatment. His contributions are paving the way for more effective therapies that could significantly impact patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…